FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2024521791> ?p ?o ?g. }

• W2024521791 endingPage "50" @default.
• W2024521791 startingPage "43" @default.
• W2024521791 abstract "Background: In progressive multiple sclerosis (PMS), disease-modifying therapies have not been shown to reduce disability progression. Objective: The impact from immunosuppressive therapy in PMS was explored by analyzing cerebrospinal fluid (CSF) biomarkers of axonal damage (neurofilament light protein, NFL), astrogliosis (glial fibrillary acidic protein, GFAP), and B-cell regulation (CXCL13). Methods: CSF was obtained from 35 patients with PMS before and after 12–24 months of mitoxantrone ( n=30) or rituximab ( n=5) treatment, and from 14 age-matched healthy control subjects. The levels of NFL, GFAP, and CXCL13 were determined by immunoassays. Results: The mean NFL level decreased by 51% (1781 ng/l, SD 2018 vs. 874 ng/l, SD 694, p=0.007), the mean CXCL13 reduction was 55% (9.71 pg/ml, SD 16.08, vs. 4.37 pg/ml, SD 1.94, p=0.008), while GFAP levels remained unaffected. Subgroup analysis showed that the NFL reduction was confined to previously untreated patients ( n=20) and patients with Gd-enhancing lesions on magnetic resonance imaging ( n=12) prior to study baseline. Conclusions: Our data imply that 12–24 months of immunosuppressive therapy reduces axonal damage in PMS, particularly in patients with ongoing disease activity. Determination of NFL levels in CSF is a potential surrogate marker for treatment efficacy and as endpoint in phase II trials of MS." @default.
• W2024521791 created "2016-06-24" @default.
• W2024521791 creator A5000664165 @default.
• W2024521791 creator A5012945005 @default.
• W2024521791 creator A5035345316 @default.
• W2024521791 creator A5041446091 @default.
• W2024521791 creator A5050988193 @default.
• W2024521791 creator A5079766290 @default.
• W2024521791 creator A5089726749 @default.
• W2024521791 date "2013-05-23" @default.
• W2024521791 modified "2023-10-03" @default.
• W2024521791 title "Immunosuppressive therapy reduces axonal damage in progressive multiple sclerosis" @default.
• W2024521791 cites W1971547969 @default.
• W2024521791 cites W1983660498 @default.
• W2024521791 cites W1984069677 @default.
• W2024521791 cites W1986008120 @default.
• W2024521791 cites W1994723621 @default.
• W2024521791 cites W2029010823 @default.
• W2024521791 cites W2046941822 @default.
• W2024521791 cites W2056465861 @default.
• W2024521791 cites W2056736742 @default.
• W2024521791 cites W2081786813 @default.
• W2024521791 cites W2087589796 @default.
• W2024521791 cites W2097669496 @default.
• W2024521791 cites W2103758700 @default.
• W2024521791 cites W2105490558 @default.
• W2024521791 cites W2107008240 @default.
• W2024521791 cites W2112165124 @default.
• W2024521791 cites W2115844603 @default.
• W2024521791 cites W2118818657 @default.
• W2024521791 cites W2119172537 @default.
• W2024521791 cites W2122545833 @default.
• W2024521791 cites W2125379328 @default.
• W2024521791 cites W2125411015 @default.
• W2024521791 cites W2139344244 @default.
• W2024521791 cites W2148333046 @default.
• W2024521791 cites W2150429740 @default.
• W2024521791 cites W2160872052 @default.
• W2024521791 cites W2163398467 @default.
• W2024521791 cites W2168726651 @default.
• W2024521791 cites W2313649737 @default.
• W2024521791 cites W2314559535 @default.
• W2024521791 cites W2574627421 @default.
• W2024521791 cites W4210548604 @default.
• W2024521791 cites W4245279901 @default.
• W2024521791 doi "https://doi.org/10.1177/1352458513490544" @default.
• W2024521791 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/23702432" @default.
• W2024521791 hasPublicationYear "2013" @default.
• W2024521791 type Work @default.
• W2024521791 sameAs 2024521791 @default.
• W2024521791 citedByCount "100" @default.
• W2024521791 countsByYear W20245217912014 @default.
• W2024521791 countsByYear W20245217912015 @default.
• W2024521791 countsByYear W20245217912016 @default.
• W2024521791 countsByYear W20245217912017 @default.
• W2024521791 countsByYear W20245217912018 @default.
• W2024521791 countsByYear W20245217912019 @default.
• W2024521791 countsByYear W20245217912020 @default.
• W2024521791 countsByYear W20245217912021 @default.
• W2024521791 countsByYear W20245217912022 @default.
• W2024521791 countsByYear W20245217912023 @default.
• W2024521791 crossrefType "journal-article" @default.
• W2024521791 hasAuthorship W2024521791A5000664165 @default.
• W2024521791 hasAuthorship W2024521791A5012945005 @default.
• W2024521791 hasAuthorship W2024521791A5035345316 @default.
• W2024521791 hasAuthorship W2024521791A5041446091 @default.
• W2024521791 hasAuthorship W2024521791A5050988193 @default.
• W2024521791 hasAuthorship W2024521791A5079766290 @default.
• W2024521791 hasAuthorship W2024521791A5089726749 @default.
• W2024521791 hasConcept C126322002 @default.
• W2024521791 hasConcept C126894567 @default.
• W2024521791 hasConcept C142724271 @default.
• W2024521791 hasConcept C203014093 @default.
• W2024521791 hasConcept C204232928 @default.
• W2024521791 hasConcept C2779338263 @default.
• W2024521791 hasConcept C2779651940 @default.
• W2024521791 hasConcept C2779965356 @default.
• W2024521791 hasConcept C2780495277 @default.
• W2024521791 hasConcept C2780640218 @default.
• W2024521791 hasConcept C2780653079 @default.
• W2024521791 hasConcept C2781197716 @default.
• W2024521791 hasConcept C529278444 @default.
• W2024521791 hasConcept C55493867 @default.
• W2024521791 hasConcept C71924100 @default.
• W2024521791 hasConcept C86803240 @default.
• W2024521791 hasConcept C90924648 @default.
• W2024521791 hasConceptScore W2024521791C126322002 @default.
• W2024521791 hasConceptScore W2024521791C126894567 @default.
• W2024521791 hasConceptScore W2024521791C142724271 @default.
• W2024521791 hasConceptScore W2024521791C203014093 @default.
• W2024521791 hasConceptScore W2024521791C204232928 @default.
• W2024521791 hasConceptScore W2024521791C2779338263 @default.
• W2024521791 hasConceptScore W2024521791C2779651940 @default.
• W2024521791 hasConceptScore W2024521791C2779965356 @default.
• W2024521791 hasConceptScore W2024521791C2780495277 @default.
• W2024521791 hasConceptScore W2024521791C2780640218 @default.
• W2024521791 hasConceptScore W2024521791C2780653079 @default.
• W2024521791 hasConceptScore W2024521791C2781197716 @default.

• next